Document is current
Any future updates will be listed below
-
Authors
Moye, Aaron L
Dost, Antonella FM
Ietswaart, Robert https://orcid.org/0000-0001-9290-4741
Sengupta, Shreoshi
Ya, VanNashlee
Aluya, Chrystal https://orcid.org/0009-0004-7157-253X
Fahey, Caroline G https://orcid.org/0000-0003-4155-5662
Louie, Sharon M
Paschini, Margherita
Kim, Carla F https://orcid.org/0000-0002-2366-9538
-
Funding
Funding for this research was provided by:
Damon Runyon Cancer Research Foundation (DRG:2368-19)
Burroughs Wellcome Fund (1019903)
Hope Funds for Cancer Research
European Molecular Biology Organization (ALTF 2016-422)
HHS | National Institutes of Health (R01 HL090136,R01 HL132266,R01 HL125821,U01 HL100402,RFA-HL-09-004,R35HL150876)
Cystic Fibrosis Foundation (KIM19P0)
Longfonds
Gilda and Alfred Slifka, Gail and Adam Slifka
Cystic Fibrosis/Multiple Sclerosis Fund Foundation
Harvard College | Harvard Stem Cell Institute
- License Information
-
More Information
Article History
Received: 27 February 2024
Revised: 4 April 2024
Accepted: 17 April 2024
First Online: 16 May 2024
Disclosure and competing interests statement
: ALM, RI, and CFK are founders of Cellforma, Inc. CFK is a member of the advisory Editorial Board of <i>The EMBO Journal</i>. This has no bearing on the editorial consideration of this article for publication.
